These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18086855)

  • 1. Systemic pharmacokinetics of rifaximin in volunteers with shigellosis.
    Taylor DN; McKenzie R; Durbin A; Carpenter C; Haake R; Bourgeois AL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1179-81. PubMed ID: 18086855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifaximin, a nonabsorbed oral antibiotic, prevents shigellosis after experimental challenge.
    Taylor DN; McKenzie R; Durbin A; Carpenter C; Atzinger CB; Haake R; Bourgeois AL
    Clin Infect Dis; 2006 May; 42(9):1283-8. PubMed ID: 16586388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case report: a case of single dose azithromycin treatment being effective for fluoroquinolone-resistant shigellosis].
    Tamura K; Fujii T; Takahashi R; Hakozaki Y
    Nihon Naika Gakkai Zasshi; 2012 Feb; 101(2):451-3. PubMed ID: 22523814
    [No Abstract]   [Full Text] [Related]  

  • 4. Cephalosporin resistant Shigella flexneri from a clinical isolate--a rare finding.
    Sabir N; Zafar A
    J Pak Med Assoc; 2005 Dec; 55(12):560-1. PubMed ID: 16438280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shigellosis in Subjects with Traveler's Diarrhea Versus Domestically Acquired Diarrhea: Implications for Antimicrobial Therapy and Human Immunodeficiency Virus Surveillance.
    Toro C; Arroyo A; Sarria A; Iglesias N; Enríquez A; Baquero M; de Guevara CL
    Am J Trop Med Hyg; 2015 Sep; 93(3):491-6. PubMed ID: 26195465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing antibiotic sensitivity patterns in shigellosis.
    Lamabadusuriya SP; Devasiri IV; Jayantha UK; Perera C
    Ceylon Med J; 1991 Dec; 36(4):159-61. PubMed ID: 1807844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers.
    Blandizzi C; Viscomi GC; Scarpignato C
    Drug Des Devel Ther; 2015; 9():1-11. PubMed ID: 25565769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shigella flexneri: an emerging pathogen.
    Nisa I; Qasim M; Yasin N; Ullah R; Ali A
    Folia Microbiol (Praha); 2020 Apr; 65(2):275-291. PubMed ID: 32026288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of in vitro and in vivo antibiotic efficacy against a novel bioluminescent Shigella flexneri.
    McCloskey MC; Shaheen S; Rabago L; Hulverson MA; Choi R; Barrett LK; Arnold SLM
    Sci Rep; 2019 Sep; 9(1):13567. PubMed ID: 31537849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shigellosis (antibiotic resistance and transfer of R-factor).
    Gaikwad S; Deodhar LP
    J Postgrad Med; 1985 Jan; 31(1):24-7. PubMed ID: 3900357
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-Shigellosis Activity of
    Wambe H; Noubissi PA; Fokam Tagne MA; Foyet Fondjo A; Fankem GO; Kamtchouing I; Ngakou Mukam J; Nguelefack TB; Kamgang R
    Biomed Res Int; 2019; 2019():6706230. PubMed ID: 31828116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is generic rifaximin still a poorly absorbed antibiotic? A comparison of branded and generic formulations in healthy volunteers.
    Blandizzi C; Viscomi GC; Marzo A; Scarpignato C
    Pharmacol Res; 2014 Jul; 85():39-44. PubMed ID: 24836868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of reduced susceptibility to fluoroquinolones in paediatric Shigella sonnei and Shigella flexneri infections.
    Thompson CN; Thieu NT; Vinh PV; Duc AN; Wolbers M; Vinh H; Campbell JI; Ngoc DT; Hoang NV; Thanh TH; The HC; Nguyen TN; Lan NP; Parry CM; Chau NV; Thwaites G; Thanh DP; Baker S
    J Antimicrob Chemother; 2016 Mar; 71(3):807-15. PubMed ID: 26679253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of virulence and antimicrobial resistance profile of Shigella species isolated from children with moderate to severe diarrhea in northeastern Brazil.
    Medeiros PHQS; Lima AÂM; Guedes MM; Havt A; Bona MD; Rey LC; Soares AM; Guerrant RL; Weigl BH; Lima IFN
    Diagn Microbiol Infect Dis; 2018 Mar; 90(3):198-205. PubMed ID: 29217418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shigellosis in Bangladesh: a reply.
    Shahid NS; Haider K; Sack DA; Rahaman MM
    J Infect Dis; 1987 Sep; 156(3):535. PubMed ID: 3302055
    [No Abstract]   [Full Text] [Related]  

  • 16. Epidemiological characterization of resistance and PCR typing of Shigella flexneri and Shigella sonnei strains isolated from bacillary dysentery cases in Southeast Brazil.
    Penatti MP; Hollanda LM; Nakazato G; Campos TA; Lancellotti M; Angellini M; Brocchi M; Rocha MM; Dias da Silveira W
    Braz J Med Biol Res; 2007 Feb; 40(2):249-58. PubMed ID: 17273662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in gyrA & parC genes of Shigella flexneri 2a determining the fluoroquinolone resistance.
    Divya MP; Mathew PD; Jyothi R; Bai R; Thomas S
    Indian J Med Res; 2015 Jun; 141(6):836-8. PubMed ID: 26205028
    [No Abstract]   [Full Text] [Related]  

  • 18. [Shigellosis in children of the IX region of Chile: clinical and epidemiologic aspects and antibiotic sensitivity].
    Boehme C; Rodríguez G; Illesca V; Reydet P; Serra J
    Rev Med Chil; 1992 Nov; 120(11):1261-6. PubMed ID: 1340946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A murine model of diarrhea, growth impairment and metabolic disturbances with
    Q S Medeiros PH; Ledwaba SE; Bolick DT; Giallourou N; Yum LK; Costa DVS; Oriá RB; Barry EM; Swann JR; Lima AÂM; Agaisse H; Guerrant RL
    Gut Microbes; 2019; 10(5):615-630. PubMed ID: 30712505
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the degree of sensitivity to antibiotics of Shigella isolated from patients with dysentery in a city infectious disease hospital over the past 8 years].
    Givental' NI; Saparov OS; Bogdanova LF; Chekrygina ON; Vel'mina EA
    Antibiot Khimioter; 1988 Feb; 33(2):135-7. PubMed ID: 3288150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.